- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01872338
Mindfulness-Based Cognitive Therapy for Suicide Prevention (MBCT-S)
April 22, 2020 updated by: VA Office of Research and Development
Mindfulness-Based Cognitive Therapy for Preventing Suicide in Military Veterans
The purpose of this study is to test a psychotherapeutic intervention that integrates cognitive therapy and mindfulness meditation techniques to prevent suicide in military Veterans.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Every month the VA becomes aware of approximately 1,100 Veterans in VA care who attempt suicide.
While the VA has implemented a comprehensive, multifaceted suicide prevention approach, it has yet to implement nationally any evidence-based psychotherapies targeting suicide, a gap due largely to the dearth of evidence-based therapies for suicide.
Primary aims of this proposal are to conduct a randomized controlled trial testing an adaptation of a cognitive-behavioral intervention, Mindfulness-Based Cognitive Therapy (MBCT), for Veterans on the VA's High Risk for Suicide List.
The investigators' adapted version of MBCT for suicide (MBCT-S) integrates mindfulness meditation techniques with the VA Safety Plan to enhance patients' awareness of suicide triggers and appropriate coping strategies.
This study has the potential to increase the range of cost effective treatment alternatives for the large number of suicidal Veterans for whom evidence-based therapies are severely limited.
Study Type
Interventional
Enrollment (Actual)
135
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
East Orange, New Jersey, United States, 07018
- East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ
-
Lyons, New Jersey, United States, 07939
- Lyons Campus of the VA New Jersey Health Care System, Lyons, NJ
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
The following criteria were formulated to recruit a sample at high risk for suicide behavior.
The subject has experienced a suicidal event during the past 30 days. A suicidal event involves
- 1) psychiatric hospitalization due to suicidal risk,
- 2) psychiatric hospitalization if subject was already on the High Risk for Suicide List,
- 3) suicidal ideation with suicidal intent,
- 4) suicidal preparatory behaviors, or
- 5) actual, interrupted, or aborted suicide attempt.
AND
The subject is on or will be placed on the VA High Risk for Suicide List
- OR The subject had an actual, interrupted, or aborted attempt in the last year
- OR In the study clinician's opinion (i.e., Masters or Doctoral level study personnel with formal mental health training) in consultation with the PI, the suicidal event is significant enough to warrant treatment to reduce suicidal risk.
Exclusion Criteria:
- cognitive deficits that decrease the likelihood of benefit from MBCT-S
- severe symptoms of hallucinations or delusions
- disorganized or disruptive behaviors
- medically unstable
- current mindfulness-based psychotherapy or receipt of 2 or more sessions of a mindfulness-based psychotherapy in the last 12 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Mindfulness-Based Cognitive Therapy + Treatment As Usual
Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
|
Psychotherapeutic intervention that integrates mindfulness meditation with Safety Planning, with a specific focus on reducing suicide risk.
Other Names:
|
|
Other: Treatment As Usual
VA standard care for suicide prevention
|
VA standard care for suicide prevention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide Event
Time Frame: 12-months post-baseline
|
The investigators define "event" broadly as a range of suicidal behaviors defined according to the VA's Self-Directed Violence Classification System (SDVCS).
Based on the SDVCS, an event may include self-directed violence, with or without injury, in which evidence of suicidal intent is clear or undetermined; or suicidal preparatory behaviors.
The study definition of a suicide event also includes suicidal ideation resulting in the need for emergency care or psychiatric hospitalization.
|
12-months post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide Attempt
Time Frame: 12 months post-baseline
|
Defined as deliberate self-directed violence with injury or potential for injury and with explicit/implicit suicidal intent
|
12 months post-baseline
|
|
Suicidal Ideation
Time Frame: Baseline, 4 weeks (mid-treatment), 8 weeks (treatment-completion), 6 months and 12-months post-baseline
|
clinician-administered Scale for Suicide Ideation (SSI), 0-38, higher score = higher suicidal ideation.
|
Baseline, 4 weeks (mid-treatment), 8 weeks (treatment-completion), 6 months and 12-months post-baseline
|
|
Hopelessness
Time Frame: Baseline, 4 weeks (mid-treatment), 8 weeks (treatment-completion), 6 months and 12-months post-baseline
|
Hopelessness will be measured using the Beck Hopelessness Scale, score range 0-20, with higher scores indicating more hopelessness.
|
Baseline, 4 weeks (mid-treatment), 8 weeks (treatment-completion), 6 months and 12-months post-baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2013
Primary Completion (Actual)
April 3, 2019
Study Completion (Actual)
April 3, 2019
Study Registration Dates
First Submitted
May 10, 2013
First Submitted That Met QC Criteria
June 4, 2013
First Posted (Estimate)
June 7, 2013
Study Record Updates
Last Update Posted (Actual)
May 5, 2020
Last Update Submitted That Met QC Criteria
April 22, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIR 12-134
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide
-
Fundació Institut de Recerca de l'Hospital de la...Not yet recruitingSuicide | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionSpain
-
University of Sao PauloNot yet recruitingSuicide Ideation | Suicide Attempts
-
Dartmouth-Hitchcock Medical CenterNational Institute of Nursing Research (NINR); Trustees of Dartmouth CollegeNot yet recruitingSuicide Attempt | Suicide IdeationUnited States
-
University of North Carolina, Chapel HillVillage Heartbeat, Inc.RecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Robert Wood Johnson FoundationRecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
Seattle Children's HospitalNationwide Children's HospitalRecruitingSuicidal Ideation | Suicide Threat | Suicide and Self-harm | Suicide AttemptsUnited States
-
Kaiser PermanenteNational Institute of Mental Health (NIMH); Henry Ford Health System; HealthPartners...Enrolling by invitationSuicide, Attempted | Suicide, FatalUnited States
-
VA Office of Research and DevelopmentRecruitingSuicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
Vestre Viken Hospital TrustSouth-Eastern Norway Regional Health AuthorityActive, not recruitingEcological Momentary Assessment | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionNorway
-
Syeda AYAT E ZAINAB AliUniversity of Leicester; University of WuerzburgRecruitingSuicide, Attempted | Suicide | Suicide Prevention | Completed SuicidePakistan
Clinical Trials on Mindfulness-Based Cognitive Therapy for Suicide
-
Oregon Health and Science UniversityTerminatedPostpartum Depression | Prenatal Stress | Maternal Psychological DistressUnited States
-
Oregon Health and Science UniversityCompletedPregnancy Related | Infant Development | Prenatal Stress | Functional Neuroimaging | Maternal Psychological DistressUnited States
-
CHA UniversityEnrolling by invitationCancer | Psychological Distress | Cancer Pain | Distress, Emotional | Therapy-Associated Cancer | Psychiatric or Mood Diseases or ConditionsKorea, Republic of
-
George Washington UniversityCompletedInsomnia | Breast Cancer FemaleUnited States
-
University of AarhusAarhus University Hospital; The Ministry of Science, Technology and Innovation...CompletedSomatization Disorder | Functional Disorders | Bodily Distress DisorderDenmark
-
University of Geneva, SwitzerlandSNF Swiss National Foundation; Geneva University Hospital, Geneva, SwitzerlandCompletedMental Health IssueSwitzerland
-
The University of Hong KongCompletedEmotional Adjustment | Mental Health IssueHong Kong
-
University of WarsawCompletedModerate Depressive Episode | Mild Depressive EpisodePoland
-
Fundació Sant Joan de DéuCarlos III Health InstituteNot yet recruitingMajor Depressive Disorder, Recurrent, in RemissionSpain
-
The University of QueenslandUniversity of Alabama at Birmingham; Rush University Medical Center; University...Completed